Paul McPherson

1.4k total citations
25 papers, 955 citations indexed

About

Paul McPherson is a scholar working on Nephrology, Epidemiology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Paul McPherson has authored 25 papers receiving a total of 955 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Nephrology, 8 papers in Epidemiology and 5 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Paul McPherson's work include Acute Kidney Injury Research (13 papers), Sepsis Diagnosis and Treatment (6 papers) and Chronic Kidney Disease and Diabetes (5 papers). Paul McPherson is often cited by papers focused on Acute Kidney Injury Research (13 papers), Sepsis Diagnosis and Treatment (6 papers) and Chronic Kidney Disease and Diabetes (5 papers). Paul McPherson collaborates with scholars based in United States, United Kingdom and France. Paul McPherson's co-authors include Kenneth F. Buechler, Robert J. Moore, Fred S. Apple, Alan H.B. Wu, G. Bodor, Yue‐Jin Feng, Daniel T. Laskowitz, G E Valkirs, Mark A. Reynolds and Jeffrey R. Dahlen and has published in prestigious journals such as Diabetes Care, Journal of the American Society of Nephrology and Critical Care Medicine.

In The Last Decade

Paul McPherson

25 papers receiving 927 citations

Peers

Countries citing papers authored by Paul McPherson

Since Specialization

Citations

This map shows the geographic impact of Paul McPherson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul McPherson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul McPherson more than expected).

Fields of papers citing papers by Paul McPherson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul McPherson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul McPherson. The network helps show where Paul McPherson may publish in the future.

Co-authorship network of co-authors of Paul McPherson

This figure shows the co-authorship network connecting the top 25 collaborators of Paul McPherson. A scholar is included among the top collaborators of Paul McPherson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul McPherson. Paul McPherson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	CCL14 testing to guide clinical practice in patients with AKI: Results from an international expert panel 2024 ·Journal of Critical Care ·John A. Kellum, Sean M. Bagshaw, Sevag Demirjian, Lui G. Forni, Michael Joannidis, J. Patrick Kampf, (unknown), (unknown), Paul McPherson, Marlies Ostermann, (unknown), (unknown), (unknown), Antoine Schneider, Ashita Tolwani, Alexander Zarbock	6
2	CCL14 Predicts Oliguria and Dialysis Requirement in Patients with Moderate to Severe Acute Kidney Injury 2024 ·Blood Purification ·Sevag Demirjian, Lakhmir S. Chawla, Danielle Davison, Lui G. Forni, Michael Heung, Eric A. J. Hoste, Jay L. Koyner, J. Patrick Kampf, (unknown), Paul McPherson, John A. Kellum	1
3	Exploring the Cost-Utility of a Biomarker Predicting Persistent Severe Acute Kidney Injury: The Case of C-C Motif Chemokine Ligand 14 (CCL14) 2024 ·ClinicoEconomics and Outcomes Research ·Jorge Echeverri, (unknown), (unknown), (unknown), Paul McPherson, Julien Textoris, Jay L. Koyner	3
4	Integrated analysis of aboveground and belowground indicators support a comprehensive evaluation of ecosystem recovery 2023 ·Restoration Ecology ·Josh Dorrough, James Val, Samantha K. Travers, Brian Wilson, David J. Eldridge, Yolima Carrillo, Uffe N. Nielsen, Jeff R. Powell, (unknown), Paul McPherson, Ian Oliver	3
5	Outcomes, Healthcare Resource Utilization, and Costs of Overall, Community-Acquired, and Hospital-Acquired Acute Kidney Injury in COVID-19 Patients 2023 ·Journal of health economics and outcomes research ·Jay L. Koyner, Rachel H. Mackey, Ning Rosenthal, (unknown), J. Patrick Kampf, Paul McPherson, (unknown), (unknown), (unknown)	2
6	CCL14 Predicts Response to Diuretics in Patients With Moderate to Severe AKI 2022 ·Journal of the American Society of Nephrology ·Sevag Demirjian, Lakhmir S. Chawla, Eric A. J. Hoste, (unknown), Jay L. Koyner, Paul McPherson, John A. Kellum	1
7	Clinical Outcomes of Persistent Severe Acute Kidney Injury among Patients with Kidney Disease Improving Global Outcomes Stage 2 or 3 Acute Kidney Injury 2022 ·American Journal of Nephrology ·Jay L. Koyner, Rachel H. Mackey, Ning Rosenthal, (unknown), J. Patrick Kampf, (unknown), (unknown), Jorge Echeverri, Paul McPherson, (unknown), Julien Textoris	13
8	Health Care Resource Utilization and Costs of Persistent Severe Acute Kidney Injury (PS-AKI) Among Hospitalized Stage 2/3 AKI Patients 2022 ·Kidney360 ·Jay L. Koyner, Rachel H. Mackey, Ning Rosenthal, (unknown), J. Patrick Kampf, Jorge Echeverri, Paul McPherson, (unknown), (unknown), (unknown), Julien Textoris	6
9	Performance of a Standardized Clinical Assay for Urinary C–C Motif Chemokine Ligand 14 (CCL14) for Persistent Severe Acute Kidney Injury 2022 ·Kidney360 ·Jay L. Koyner, Lakhmir S. Chawla, Azra Bihorac, Kyle J. Gunnerson, Rebecca A. Schroeder, Sevag Demirjian, Luke Hodgson, Jennifer A. Frey, Scott T. Wilber, J. Patrick Kampf, (unknown), Paul McPherson, John A. Kellum	29
10	External validation of urinary C–C motif chemokine ligand 14 (CCL14) for prediction of persistent acute kidney injury 2021 ·Critical Care ·Sean M. Bagshaw, Ali Al‐Khafaji, Antonio Artigas, Danielle Davison, Michael Haase, Matthew Lissauer, Kai Zacharowski, Lakhmir S. Chawla, (unknown), J. Patrick Kampf, Paul McPherson, John A. Kellum	40
11	Use of Biomarkers to Identify Acute Kidney Injury to Help Detect Sepsis in Patients With Infection 2021 ·Critical Care Medicine ·John A. Kellum, Antonio Artigas, Kyle J. Gunnerson, Patrick M. Honoré, J. Patrick Kampf, (unknown), Paul McPherson, H. Bryant Nguyen, Thomas Rimmelé, Nathan I. Shapiro, Jing Shi, Jean‐Louis Vincent, Lakhmir S. Chawla	19
12	Identification and validation of biomarkers of persistent acute kidney injury: the RUBY study 2020 ·Intensive Care Medicine ·(unknown), Eric A. J. Hoste, Azra Bihorac, Ali Al‐Khafaji, Luís Ortega, Marlies Ostermann, Michael Haase, Kai Zacharowski, Richard G. Wunderink, Michael Heung, Matthew Lissauer, Wesley H. Self, Jay L. Koyner, Patrick M. Honoré, John R. Prowle, Michael Joannidis, Lui G. Forni, J. Patrick Kampf, Paul McPherson, John A. Kellum, Lakhmir S. Chawla	152
13	Serial Urinary Tissue Inhibitor of Metalloproteinase-2 and Insulin-Like Growth Factor-Binding Protein 7 and the Prognosis for Acute Kidney Injury over the Course of Critical Illness 2019 ·Cardiorenal Medicine ·Peter A. McCullough, Marlies Ostermann, Lui G. Forni, Azra Bihorac, Jay L. Koyner, Lakhmir S. Chawla, Jing Shi, J. Patrick Kampf, Paul McPherson, John A. Kellum, (unknown)	12
14	Providers' Ability to Identify Sentinel Injuries Concerning for Physical Abuse in Infants 2018 ·Pediatric Emergency Care ·Emily A. Eismann, Robert A. Shapiro, Jonathan D. Thackeray, Kathi L. Makoroff, (unknown), Grace Kim, (unknown), Paul McPherson, (unknown), Sandra P. Spencer	7
15	Acute kidney injury: New biomarkers detect risk for this silent killer. 2015 ·PubMed ·Denise Uettwiller-Geiger, Paul McPherson	1
16	Barriers to Successful Treatment Completion in Child Sexual Abuse Survivors 2011 ·Journal of Interpersonal Violence ·Paul McPherson, Philip V. Scribano, Jack Stevens	29
17	Ohio Child and Adolescent Sexual Abuse Protocol 2009 ·CORE Scholar (Wright State University) ·Berkeley L. Bennett, Elizabeth Benzinger, (unknown), (unknown), (unknown), Gail Hornor, (unknown), (unknown), (unknown), Lolita McDavid, (unknown), Paul McPherson, Kathi L. Makoroff, Philip V. Scribano, (unknown), Jonathan D. Thackeray, (unknown)	1
18	HYPOTONIC-HYPORESPONSIVE EPISODE IN A 7-MONTH-OLD INFANT AFTER RECEIPT OF MULTIPLE VACCINATIONS 2005 ·The Pediatric Infectious Disease Journal ·Paul McPherson, Keith R. Powell	2
19	The Triage Cardiac Panel 2002 ·Point of Care The Journal of Near-Patient Testing & Technology ·Thomas J. Clark, Paul McPherson, Kenneth F. Buechler	42
20	Characterization of cardiac troponin subunit release into serum after acute myocardial infarction and comparison of assays for troponin T and I 1998 ·Clinical Chemistry ·Alan H.B. Wu, Yue‐Jin Feng, Robert J. Moore, Fred S. Apple, Paul McPherson, Kenneth F. Buechler, G. Bodor	323

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact